Comparative Study
doi: 10.1016/s0006-291x(88)80950-1.
Potent and selective activity of a new carbocyclic nucleoside analog (carbovir: NSC 614846) against human immunodeficiency virus in vitro
Affiliations
- PMID: 2847711
- DOI: 10.1016/s0006-291x(88)80950-1
Item in Clipboard
Comparative Study
Potent and selective activity of a new carbocyclic nucleoside analog (carbovir: NSC 614846) against human immunodeficiency virus in vitro
Biochem Biophys Res Commun.
.
Abstract
Carbocyclic 2',3'-didehydro-2',3'-dideoxyguanosine (Carbovir: NSC 614846), a novel nucleoside analog, emerged as a potent and selective anti-HIV agent from a large screening program conducted by the National Cancer Institute and its contractors. Its hydrolytic stability and its ability to inhibit the infectivity and replication of HIV in T-cells at concentrations of approximately 200- to 400-fold below toxic concentrations make carbovir a top-priority candidate for development as a potential antiretroviral agent in the treatment of AIDS patients.
Similar articles
-
Synthesis and anti-HIV activity of carbocyclic 2',3'-didehydro-2',3'-dideoxy 2,6-disubstituted purine nucleosides.J Med Chem. 1990 Jan;33(1):17-21. doi: 10.1021/jm00163a004. J Med Chem. 1990. PMID: 2296018
-
Synthesis and anti-HIV activity of carbovir and related carbocyclic nucleosides.Nucleic Acids Symp Ser. 1991;(25):193-4. Nucleic Acids Symp Ser. 1991. PMID: 1842080
-
Carbovir: the (-) enantiomer is a potent and selective antiviral agent against human immunodeficiency virus in vitro.Antiviral Res. 1991 Feb;15(2):161-8. doi: 10.1016/0166-3542(91)90033-n. Antiviral Res. 1991. PMID: 1677557
-
Targets for antiviral therapy of human immunodeficiency virus infection.J Infect. 1989 Jan;18 Suppl 1:5-13. doi: 10.1016/s0163-4453(89)80075-1. J Infect. 1989. PMID: 2464649 Review.
-
Targeted therapy of human immunodeficiency virus-related disease.FASEB J. 1991 Jul;5(10):2369-81. doi: 10.1096/fasebj.5.10.1712326. FASEB J. 1991. PMID: 1712326 Review.
Cited by
-
Cyclobut-A and cyclobut-G, carbocyclic oxetanocin analogs that inhibit the replication of human immunodeficiency virus in T cells and monocytes and macrophages in vitro.Antimicrob Agents Chemother. 1990 Feb;34(2):287-94. doi: 10.1128/AAC.34.2.287. Antimicrob Agents Chemother. 1990. PMID: 2327778 Free PMC article.
-
Comparative brain exposure to (-)-carbovir after (-)-carbovir or (-)-6-aminocarbovir intravenous infusion in rats.Pharm Res. 1995 Jun;12(6):911-5. doi: 10.1023/a:1016229624703. Pharm Res. 1995. PMID: 7667200
-
Antiviral therapy in human immunodeficiency virus infection.Drugs. 1989 Sep;38(3):417-50. doi: 10.2165/00003495-198938030-00005. Drugs. 1989. PMID: 2680436 Review.
-
Activities of (-)-carbovir and 3'-azido-3'-deoxythymidine against human immunodeficiency virus in vitro.Antimicrob Agents Chemother. 1990 Jun;34(6):1297-300. doi: 10.1128/AAC.34.6.1297. Antimicrob Agents Chemother. 1990. PMID: 2393292 Free PMC article.
-
Novel Isoxazolidine and γ-Lactam Analogues of Homonucleosides.Molecules. 2019 Nov 6;24(22):4014. doi: 10.3390/molecules24224014. Molecules. 2019. PMID: 31698778 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
